Status:
ENROLLING_BY_INVITATION
Behavioral Intervention for Celiac Disease
Lead Sponsor:
Children's National Research Institute
Collaborating Sponsors:
Children's Hospital Colorado
Conditions:
Celiac Disease
Eligibility:
All Genders
12-16 years
Phase:
NA
Brief Summary
Celiac disease (CD) is a chronic autoimmune condition whose only currently available treatment is a strict, burdensome gluten-free diet (GFD). The current proposal uses a theory-driven empirical appro...
Detailed Description
Celiac Disease (CD) is an increasingly common disease with significant morbidities if treatment is not achieved. The incidence and prevalence of CD has been increasing in children and teens over the p...
Eligibility Criteria
Inclusion
- Teens with a physician- confirmed CD diagnosis and one parent or guardian.
- Teens 12-16 years at the time of enrollment.
- Proficient in written and spoken English.
- Have regular access to a device enabled for video conferencing (Zoom) and receiving SMS messages.
Exclusion
- The teen's CD diagnosis is questioned or revoked at any time during the study period;
- Another member of their household is already enrolled in the study;
- The teen has a developmental disability or major neuropsychological condition that, in the opinion of the investigators, would impair communication and engagement with the other participants and intervention material.
Key Trial Info
Start Date :
June 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT05204446
Start Date
June 7 2022
End Date
October 1 2026
Last Update
July 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's National Hospital
Washington D.C., District of Columbia, United States, 20010